A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and ...

If you think a galaxy is big, compare it to the size of the universe: it's just a tiny dot which, together with a huge number ...

Researchers have crunched data on excess deaths and calculated that Canada’s 2023 wildfire season shortened the lives of ...

In two new studies, scientists at Oregon Health & Science University have uncovered detailed blueprints of how certain molecular "gates" in human cells work—findings that could open doors to new ...

Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients• For eligible and willing ...

A new study shows that a TXA autoinjector delivers lifesaving treatment for severe bleeding as effectively as traditional IV ...

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

The drugs significantly improved the youngsters' blood sugar control and weight but those using them suffered common side-effects.

Antimicrobial stewardship matters, and pediatric hospitalists are important team members, experts say. Here is what to know ...

"The cheating is off the charts. It's the worst I've seen in my entire career," says Casey Cuny, who has taught English for 23 years.

Britons are now vaping in unprecedented numbers - around one in ten adults (9.8 per cent) in 2023, rising to 15.8 per cent ...

By Dennis Thompson HealthDay ReporterMONDAY, Sept. 15, 2025 (HealthDay News) — The benefits of psilocybin treatment for ...